Product Information
ATORVASTATIN 10 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0232 per EA under NDC 82009017610. Its NADAC has been published 46 times since Oct 8, 2025.
FDA first approved this application on Sep 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009017610
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214344FDA Approved
9/12/2023
TE Code
AB
On Market Since
8/1/2025
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 10 MG TABLET has been published 46 times since Oct 8, 2025, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0232 per EA |
|---|---|
| All-time high | $0.0258 (Feb 11, 2026) |
| All-time low | $0.0232 (Aug 19, 2026) |
| 52-week high | $0.0258 |
| 52-week low | $0.0232 |
| Median price | $0.0248 |
| Average price | $0.0249 |
| Largest weekly change | +3.6% (Dec 17, 2025) |
| Weeks tracked | 46 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0232 per EA (NDC 82009017610), effective Aug 19, 2026.
How has the price of ATORVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has declined 6.2%. It has been tracked across 46 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?
Since Oct 8, 2025, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0232 (Aug 19, 2026) to a high of $0.0258 (Feb 11, 2026), with a median of $0.0248 per EA.
Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 10 MG TABLET?
ATORVASTATIN 10 MG TABLET (NDC 82009017610) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.